Takeda Pharmaceutical
315 hedge funds and large institutions have $1.97B invested in Takeda Pharmaceutical in 2021 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 107 increasing their positions, 70 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
7% more call options, than puts
Call options by funds: $95.8M | Put options by funds: $89.6M
0.06% less ownership
Funds ownership: 6.9% → 6.84% (-0.06%)
0% less capital invested
Capital invested by funds: $1.98B → $1.97B (-$9.3M)
Holders
315
Holding in Top 10
5
Calls
$95.8M
Puts
$89.6M
Top Buyers
| 1 | +$184M | |
| 2 | +$34M | |
| 3 | +$25M | |
| 4 |
GCM
Glenview Capital Management
New York
|
+$15.4M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$13.4M |
Top Sellers
| 1 | -$138M | |
| 2 | -$120M | |
| 3 | -$39.2M | |
| 4 |
TAM
TFG Asset Management
Grand Cayman,
Cayman Islands
|
-$15.6M |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$14.3M |